1. Home
  2. EVGN vs LAES Comparison

EVGN vs LAES Comparison

Compare EVGN & LAES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVGN
  • LAES
  • Stock Information
  • Founded
  • EVGN 1999
  • LAES 2022
  • Country
  • EVGN Israel
  • LAES Switzerland
  • Employees
  • EVGN N/A
  • LAES N/A
  • Industry
  • EVGN Agricultural Chemicals
  • LAES Semiconductors
  • Sector
  • EVGN Industrials
  • LAES Technology
  • Exchange
  • EVGN Nasdaq
  • LAES Nasdaq
  • Market Cap
  • EVGN 15.8M
  • LAES 12.6M
  • IPO Year
  • EVGN N/A
  • LAES N/A
  • Fundamental
  • Price
  • EVGN $2.82
  • LAES $0.43
  • Analyst Decision
  • EVGN Strong Buy
  • LAES Strong Buy
  • Analyst Count
  • EVGN 1
  • LAES 1
  • Target Price
  • EVGN $12.00
  • LAES $1.75
  • AVG Volume (30 Days)
  • EVGN 22.9K
  • LAES 441.3K
  • Earning Date
  • EVGN 11-13-2024
  • LAES 09-25-2024
  • Dividend Yield
  • EVGN N/A
  • LAES N/A
  • EPS Growth
  • EVGN N/A
  • LAES N/A
  • EPS
  • EVGN N/A
  • LAES N/A
  • Revenue
  • EVGN $9,449,000.00
  • LAES $20,135,000.00
  • Revenue This Year
  • EVGN $173.12
  • LAES N/A
  • Revenue Next Year
  • EVGN $33.10
  • LAES N/A
  • P/E Ratio
  • EVGN N/A
  • LAES N/A
  • Revenue Growth
  • EVGN 290.29
  • LAES N/A
  • 52 Week Low
  • EVGN $2.29
  • LAES $0.29
  • 52 Week High
  • EVGN $10.40
  • LAES $3.95
  • Technical
  • Relative Strength Index (RSI)
  • EVGN 42.32
  • LAES 41.90
  • Support Level
  • EVGN $2.63
  • LAES $0.40
  • Resistance Level
  • EVGN $3.32
  • LAES $0.54
  • Average True Range (ATR)
  • EVGN 0.26
  • LAES 0.04
  • MACD
  • EVGN 0.09
  • LAES -0.00
  • Stochastic Oscillator
  • EVGN 51.46
  • LAES 20.56

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.

About LAES SEALSQ Corp

SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. Its vaultIC range offers a complete set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.

Share on Social Networks: